Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 9 July 2004:
Vol. 305. no. 5681, pp. 209 - 212
DOI: 10.1126/science.1099538
Prev | Table of Contents | Next

Viewpoint

Exploiting Tolerance Processes in Transplantation

Herman Waldmann* and Stephen Cobbold

The full potential of organ transplantation has not yet been realized because of the hazards associated with the long-term use of immunosuppressive drugs. Modern research into mechanisms of immune tolerance offers the promise of reprogramming the immune system, so as to harness the body's natural tolerance mechanisms in the service of graft acceptance. This would allow the minimization of immunosuppressive treatment and offers the prospect of eventually weaning transplant recipients off their drugs.

Sir William Dunn School of Pathology, South Parks Road, Oxford OX13RE, UK.

* To whom correspondence should be addressed. E-mail herman.waldmann{at}path.ox.ac.uk

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Antigen-Driven Interactions with Dendritic Cells and Expansion of Foxp3+ Regulatory T Cells Occur in the Absence of Inflammatory Signals.
P. Chappert, M. Leboeuf, P. Rameau, D. Stockholm, R. Liblau, O. Danos, J. M. Davoust, and D.-A. Gross (2008)
J. Immunol. 180, 327-334
   Abstract »    Full Text »    PDF »
Double-Negative T Cells, Activated by Xenoantigen, Lyse Autologous B and T Cells Using a Perforin/Granzyme-Dependent, Fas-Fas Ligand-Independent Pathway.
Z.-X. Zhang, Y. Ma, H. Wang, J. Arp, J. Jiang, X. Huang, K. M. He, B. Garcia, J. Madrenas, and R. Zhong (2006)
J. Immunol. 177, 6920-6929
   Abstract »    Full Text »    PDF »
Simple conditioning with monospecific CD4+CD25+ regulatory T cells for bone marrow engraftment and tolerance to multiple gene products.
D.-A. Gross, P. Chappert, M. Leboeuf, V. Monteilhet, L. Van Wittenberghe, O. Danos, and J. Davoust (2006)
Blood 108, 1841-1848
   Abstract »    Full Text »    PDF »
CD4+ regulatory cells as a potential immunotherapy.
Z. Fehervari and S. Sakaguchi (2005)
Phil Trans R Soc B 360, 1647-1661
   Abstract »    Full Text »    PDF »
Immunomodulation of Atherosclerosis: Implications for Vaccine Development.
J. Nilsson, G. K. Hansson, and P. K. Shah (2005)
Arterioscler. Thromb. Vasc. Biol. 25, 18-28
   Abstract »    Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)